The European Union is preparing for a possible vaccination campaign in the autumn.
Moderna has agreed to postpone certain deliveries of coronavirus vaccines to the European Union for several months.
Shares of Moderna fell nearly 2% due to the delay, although the company kept its forecast for vaccine sales of $ 21 billion for 2022.
The delivery of the installments was originally scheduled for the second quarter, the European Commission said.
The European Union also amended agreements with Pfizer BioNTech in April to delay vaccine deliveries by three months as it prepares for a possible aid campaign in the autumn.
The agreement helps “optimize supply arrangements and align them with current demand levels in our Member States,” said Stella Kyriakidi, Commissioner for Health and Food Safety.
Swiss health officials said last week that the country would destroy more than 620,000 expired doses of Moderna’s COVID-19 vaccine as demand for the vaccine plummeted.
Under the amended agreement with Moderna, EU countries will also have access to a next-generation vaccine targeting both the Omicron variant and the original strain, if approved.
